20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DOFETILIDE USP, with a corresponding US DMF Number 31811.
Remarkably, this DMF maintains an Active status since its submission on August 10, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2018, and payment made on August 01, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II